{"id":"https://openalex.org/W4402640824","doi":"https://doi.org/10.1080/17568919.2024.2394016","title":"Structure\u2013activity relationships study of N -ethylene glycol-comprising alkyl heterocyclic carboxamides against A549 lung cancer cells","display_name":"Structure\u2013activity relationships study of N -ethylene glycol-comprising alkyl heterocyclic carboxamides against A549 lung cancer cells","publication_year":2024,"publication_date":"2024-09-19","ids":{"openalex":"https://openalex.org/W4402640824","doi":"https://doi.org/10.1080/17568919.2024.2394016","pmid":"https://pubmed.ncbi.nlm.nih.gov/39297548","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11559366"},"language":"en","primary_location":{"id":"doi:10.1080/17568919.2024.2394016","doi":"https://doi.org/10.1080/17568919.2024.2394016","is_oa":false,"landing_page_url":"https://doi.org/10.1080/17568919.2024.2394016","pdf_url":null,"source":{"id":"https://openalex.org/S122867665","display_name":"Future Medicinal Chemistry","issn_l":"1756-8919","issn":["1756-8919","1756-8927"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11559366/pdf/IFMC_16_2394016.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032430161","display_name":"Kaito Ohta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kaito Ohta","raw_affiliation_strings":["Kyoto Pharmaceutical University","Laboratory of Pharmaceutical Manufacturing Chemistry","Laboratory of Pharmaceutical Manufacturing Chemistry, Kyoto Pharmaceutical University, 1 Misasagi-Shichono-cho, Yamashina-ku, Kyoto, 607-8412, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyoto Pharmaceutical University","institution_ids":["https://openalex.org/I25998863"]},{"raw_affiliation_string":"Laboratory of Pharmaceutical Manufacturing Chemistry","institution_ids":[]},{"raw_affiliation_string":"Laboratory of Pharmaceutical Manufacturing Chemistry, Kyoto Pharmaceutical University, 1 Misasagi-Shichono-cho, Yamashina-ku, Kyoto, 607-8412, Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081413962","display_name":"Hiromi Ii","orcid":"https://orcid.org/0000-0003-1152-7767","observed_orcids":["https://orcid.org/0000-0003-1152-7767"]},"institutions":[{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiromi Ii","raw_affiliation_strings":["Kyoto Pharmaceutical University","Laboratory of Clinical Oncology","Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, 5 Misasagi-Nakauchi-cho, Yamashina-ku, Kyoto, 607-8414, Japan"],"raw_orcid":"https://orcid.org/0000-0003-1152-7767","affiliations":[{"raw_affiliation_string":"Kyoto Pharmaceutical University","institution_ids":["https://openalex.org/I25998863"]},{"raw_affiliation_string":"Laboratory of Clinical Oncology","institution_ids":[]},{"raw_affiliation_string":"Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, 5 Misasagi-Nakauchi-cho, Yamashina-ku, Kyoto, 607-8414, Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113822640","display_name":"Mei Takahashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mei Takahashi","raw_affiliation_strings":["Kyoto Pharmaceutical University","Laboratory of Pharmaceutical Manufacturing Chemistry","Laboratory of Pharmaceutical Manufacturing Chemistry, Kyoto Pharmaceutical University, 1 Misasagi-Shichono-cho, Yamashina-ku, Kyoto, 607-8412, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyoto Pharmaceutical University","institution_ids":["https://openalex.org/I25998863"]},{"raw_affiliation_string":"Laboratory of Pharmaceutical Manufacturing Chemistry","institution_ids":[]},{"raw_affiliation_string":"Laboratory of Pharmaceutical Manufacturing Chemistry, Kyoto Pharmaceutical University, 1 Misasagi-Shichono-cho, Yamashina-ku, Kyoto, 607-8412, Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079079615","display_name":"Chiami Moyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chiami Moyama","raw_affiliation_strings":["Kyoto Pharmaceutical University","Laboratory of Clinical Oncology","Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, 5 Misasagi-Nakauchi-cho, Yamashina-ku, Kyoto, 607-8414, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyoto Pharmaceutical University","institution_ids":["https://openalex.org/I25998863"]},{"raw_affiliation_string":"Laboratory of Clinical Oncology","institution_ids":[]},{"raw_affiliation_string":"Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, 5 Misasagi-Nakauchi-cho, Yamashina-ku, Kyoto, 607-8414, Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002674449","display_name":"Shota Ando","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shota Ando","raw_affiliation_strings":["Kyoto Pharmaceutical University","Laboratory of Clinical Oncology","Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, 5 Misasagi-Nakauchi-cho, Yamashina-ku, Kyoto, 607-8414, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyoto Pharmaceutical University","institution_ids":["https://openalex.org/I25998863"]},{"raw_affiliation_string":"Laboratory of Clinical Oncology","institution_ids":[]},{"raw_affiliation_string":"Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, 5 Misasagi-Nakauchi-cho, Yamashina-ku, Kyoto, 607-8414, Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109176383","display_name":"Masaya Mori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaya Mori","raw_affiliation_strings":["Kyoto Pharmaceutical University","Laboratory of Clinical Oncology","Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, 5 Misasagi-Nakauchi-cho, Yamashina-ku, Kyoto, 607-8414, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyoto Pharmaceutical University","institution_ids":["https://openalex.org/I25998863"]},{"raw_affiliation_string":"Laboratory of Clinical Oncology","institution_ids":[]},{"raw_affiliation_string":"Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, 5 Misasagi-Nakauchi-cho, Yamashina-ku, Kyoto, 607-8414, Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111332510","display_name":"Maho Masuda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Maho Masuda","raw_affiliation_strings":["Kyoto Pharmaceutical University","Laboratory of Clinical Oncology","Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, 5 Misasagi-Nakauchi-cho, Yamashina-ku, Kyoto, 607-8414, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyoto Pharmaceutical University","institution_ids":["https://openalex.org/I25998863"]},{"raw_affiliation_string":"Laboratory of Clinical Oncology","institution_ids":[]},{"raw_affiliation_string":"Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, 5 Misasagi-Nakauchi-cho, Yamashina-ku, Kyoto, 607-8414, Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004951979","display_name":"Hisanori Nambu","orcid":"https://orcid.org/0000-0002-5186-8868","observed_orcids":["https://orcid.org/0000-0002-5186-8868"]},"institutions":[{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hisanori Nambu","raw_affiliation_strings":["Kyoto Pharmaceutical University","Laboratory of Pharmaceutical Manufacturing Chemistry","Laboratory of Pharmaceutical Manufacturing Chemistry, Kyoto Pharmaceutical University, 1 Misasagi-Shichono-cho, Yamashina-ku, Kyoto, 607-8412, Japan"],"raw_orcid":"https://orcid.org/0000-0002-5186-8868","affiliations":[{"raw_affiliation_string":"Kyoto Pharmaceutical University","institution_ids":["https://openalex.org/I25998863"]},{"raw_affiliation_string":"Laboratory of Pharmaceutical Manufacturing Chemistry","institution_ids":[]},{"raw_affiliation_string":"Laboratory of Pharmaceutical Manufacturing Chemistry, Kyoto Pharmaceutical University, 1 Misasagi-Shichono-cho, Yamashina-ku, Kyoto, 607-8412, Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025287238","display_name":"Susumu Nakata","orcid":"https://orcid.org/0000-0002-9950-7543","observed_orcids":["https://orcid.org/0000-0002-9950-7543"]},"institutions":[{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Susumu Nakata","raw_affiliation_strings":["Kyoto Pharmaceutical University","Laboratory of Clinical Oncology","Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, 5 Misasagi-Nakauchi-cho, Yamashina-ku, Kyoto, 607-8414, Japan"],"raw_orcid":"https://orcid.org/0000-0002-9950-7543","affiliations":[{"raw_affiliation_string":"Kyoto Pharmaceutical University","institution_ids":["https://openalex.org/I25998863"]},{"raw_affiliation_string":"Laboratory of Clinical Oncology","institution_ids":[]},{"raw_affiliation_string":"Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, 5 Misasagi-Nakauchi-cho, Yamashina-ku, Kyoto, 607-8414, Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005153343","display_name":"Naoto Kojima","orcid":"https://orcid.org/0000-0002-4544-4583","observed_orcids":["https://orcid.org/0000-0002-4544-4583"]},"institutions":[{"id":"https://openalex.org/I21361538","display_name":"Nagasaki International University","ror":"https://ror.org/01tqqny90","country_code":"JP","type":"education","lineage":["https://openalex.org/I21361538"]},{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Naoto Kojima","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences","Kyoto Pharmaceutical University","Laboratory of Pharmaceutical Manufacturing Chemistry","Nagasaki International University","Faculty of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch Machi, Sasebo, Nagasaki, 859-3298, Japan","Laboratory of Pharmaceutical Manufacturing Chemistry, Kyoto Pharmaceutical University, 1 Misasagi-Shichono-cho, Yamashina-ku, Kyoto, 607-8412, Japan"],"raw_orcid":"https://orcid.org/0000-0002-4544-4583","affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences","institution_ids":[]},{"raw_affiliation_string":"Kyoto Pharmaceutical University","institution_ids":["https://openalex.org/I25998863"]},{"raw_affiliation_string":"Laboratory of Pharmaceutical Manufacturing Chemistry","institution_ids":[]},{"raw_affiliation_string":"Nagasaki International University","institution_ids":["https://openalex.org/I21361538"]},{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch Machi, Sasebo, Nagasaki, 859-3298, Japan","institution_ids":["https://openalex.org/I21361538"]},{"raw_affiliation_string":"Laboratory of Pharmaceutical Manufacturing Chemistry, Kyoto Pharmaceutical University, 1 Misasagi-Shichono-cho, Yamashina-ku, Kyoto, 607-8412, Japan","institution_ids":["https://openalex.org/I25998863"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5005153343"],"corresponding_institution_ids":["https://openalex.org/I21361538","https://openalex.org/I25998863"],"apc_list":null,"apc_paid":null,"fwci":0.139,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.27835502,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"16","issue":"20","first_page":"2135","last_page":"2150"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8140000104904175},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8399999737739563},{"id":"https://openalex.org/keywords/a549-cells","display_name":"A549 cells","score":0.9890000224113464},{"id":"https://openalex.org/keywords/oxidative-phosphorylation-inhibition","display_name":"oxidative phosphorylation inhibition","score":0.875},{"id":"https://openalex.org/keywords/mitochondrial-inhibitors","display_name":"mitochondrial inhibitors","score":0.8209999799728394},{"id":"https://openalex.org/keywords/tetraethylene-glycol","display_name":"tetraethylene glycol","score":0.8870000243186951},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.7089999914169312},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.453000009059906}],"concepts":[{"id":"https://openalex.org/C2780263894","wikidata":"https://www.wikidata.org/wiki/Q335268","display_name":"Alkyl","level":2,"score":0.7398034930229187},{"id":"https://openalex.org/C2777516009","wikidata":"https://www.wikidata.org/wiki/Q194207","display_name":"Ethylene glycol","level":2,"score":0.6122179627418518},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5772780179977417},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5658385753631592},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5543010830879211},{"id":"https://openalex.org/C2778597550","wikidata":"https://www.wikidata.org/wiki/Q151313","display_name":"Ethylene","level":3,"score":0.5153653025627136},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.46085065603256226},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.44797059893608093},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.41204190254211426},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3763645589351654},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35815179347991943},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3339914083480835},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28492796421051025},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.26035362482070923},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.23299649357795715},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22829511761665344},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1799132525920868},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.14582857489585876},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000072283","descriptor_name":"A549 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006571","descriptor_name":"Heterocyclic Compounds","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D006571","descriptor_name":"Heterocyclic Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006571","descriptor_name":"Heterocyclic Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019855","descriptor_name":"Ethylene Glycol","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1080/17568919.2024.2394016","doi":"https://doi.org/10.1080/17568919.2024.2394016","is_oa":false,"landing_page_url":"https://doi.org/10.1080/17568919.2024.2394016","pdf_url":null,"source":{"id":"https://openalex.org/S122867665","display_name":"Future Medicinal Chemistry","issn_l":"1756-8919","issn":["1756-8919","1756-8927"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:11253004","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11559366","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11559366/pdf/IFMC_16_2394016.pdf","source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:39297548","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39297548","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11559366","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11559366/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Med Chem","raw_type":"Text"},{"id":"pmh:oai:figshare.com:article/27061575","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Structure_activity_relationships_study_of_i_N_i_-ethylene_glycol-comprising_alkyl_heterocyclic_carboxamides_against_A549_lung_cancer_cells/27061575","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"doi:10.6084/m9.figshare.27061575.v1","doi":"https://doi.org/10.6084/m9.figshare.27061575.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.27061575.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:11253004","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11559366","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11559366/pdf/IFMC_16_2394016.pdf","source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2463313775","display_name":null,"funder_award_id":"S1511024L","funder_id":"https://openalex.org/F4320320912","funder_display_name":"Ministry of Education, Culture, Sports, Science and Technology"},{"id":"https://openalex.org/G2483331476","display_name":"Structure-activity relationship studies on the THF ring moiety of acetogenin analogs for the discovery of novel anticancer agents","funder_award_id":"16K08330","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G4270726795","display_name":"A novel cancer therapeutic strategy that enhances ferroptosis by dual inhibition of GGCT and xCT","funder_award_id":"22K06756","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G583685443","display_name":"\u81a0\u82bd\u816b\u5e79\u7d30\u80de\u306e\u5897\u6b96\u3092\u963b\u5bb3\u3059\u308b\u65b0\u898f\u30c1\u30aa\u30d5\u30a7\u30f3\u30ab\u30eb\u30dc\u30ad\u30b5\u30df\u30c9\u8a98\u5c0e\u4f53\u306e\u5408\u6210\u7814\u7a76","funder_award_id":"24K09742","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G6179571054","display_name":null,"funder_award_id":"16K08330 and 24K09742","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320316815","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10"},{"id":"https://openalex.org/F4320320912","display_name":"Ministry of Education, Culture, Sports, Science and Technology","ror":"https://ror.org/048rj2z13"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4402640824.pdf","grobid_xml":"https://content.openalex.org/works/W4402640824.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1979043912","https://openalex.org/W1991445841","https://openalex.org/W2023217997","https://openalex.org/W2032991535","https://openalex.org/W2040012155","https://openalex.org/W2040532193","https://openalex.org/W2044659597","https://openalex.org/W2064964839","https://openalex.org/W2074999513","https://openalex.org/W2093539367","https://openalex.org/W2102322990","https://openalex.org/W2130701925","https://openalex.org/W2148787178","https://openalex.org/W2395441025","https://openalex.org/W2472596403","https://openalex.org/W2584378351","https://openalex.org/W2593436234","https://openalex.org/W2801176499","https://openalex.org/W2898331982","https://openalex.org/W2953227922","https://openalex.org/W2968141411","https://openalex.org/W3010888591","https://openalex.org/W3017907928","https://openalex.org/W3039902956","https://openalex.org/W3093329155","https://openalex.org/W3138122394","https://openalex.org/W3204631813","https://openalex.org/W3209437575","https://openalex.org/W4205677919","https://openalex.org/W4220685836","https://openalex.org/W4281704132","https://openalex.org/W4282942252","https://openalex.org/W4285389935","https://openalex.org/W4307884544","https://openalex.org/W4308186495","https://openalex.org/W4365997891","https://openalex.org/W4367307094","https://openalex.org/W4380870727"],"related_works":["https://openalex.org/W3008065080","https://openalex.org/W2074999513","https://openalex.org/W3204631813","https://openalex.org/W4307884544","https://openalex.org/W3034639274","https://openalex.org/W2922058242","https://openalex.org/W2963269760","https://openalex.org/W2792156679","https://openalex.org/W2067620141","https://openalex.org/W4292169580"],"abstract_inverted_index":{"Aim:":[0],"Certain":[1],"cancer":[2,62,114],"cells":[3],"depend":[4],"on":[5,57],"oxidative":[6],"phosphorylation":[7],"for":[8,53,110],"survival;":[9],"thus,":[10],"inhibiting":[11],"this":[12],"process":[13],"may":[14,104],"be":[15,105],"a":[16,106],"promising":[17],"treatment":[18],"strategy.":[19],"This":[20],"study":[21],"explored":[22],"the":[23,27,68],"structure\u2013activity":[24],"relationships":[25],"of":[26,70],"mitochondrial":[28],"inhibitor":[29],"N-ethylene":[30],"glycol-comprising":[31],"alkyl":[32],"thiophene-3-carboxamide":[33],"3.Methods":[34],"&":[35],"results:":[36],"We":[37,64],"synthesized":[38],"and":[39,50],"evaluated":[40],"13":[41],"analogs":[42,79],"(5a\u2013m)":[43],"with":[44],"different":[45],"ethylene":[46,71],"glycol":[47,72,94],"units,":[48,95],"heterocycles":[49],"connecting":[51],"groups":[52],"their":[54],"growth-inhibitory":[55],"effects":[56],"A549":[58],"non-small":[59,111],"cell":[60,112],"lung":[61,113],"cells.":[63],"found":[65],"that":[66],"increasing":[67],"number":[69],"units":[73],"significantly":[74,96],"enhanced":[75],"inhibitory":[76],"activity.":[77],"Some":[78],"activated":[80],"adenosine":[81],"monophosphate-activated":[82],"protein":[83],"kinase,":[84],"similar":[85],"to":[86],"3.":[87],"Notably,":[88],"analog":[89],"5e,":[90],"which":[91],"contains":[92],"tetraethylene":[93],"inhibited":[97],"tumor":[98],"growth":[99],"in":[100],"vivo.Conclusion:":[101],"Analog":[102],"5":[103],"potential":[107],"therapeutic":[108],"agent":[109],"treatment.":[115]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-09-20T00:00:00"}